Allantoin
尿囊素
Report date: 2026/03/20 20:03:07
Base Information
Drug NameAllantoin
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[15]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesScioderm Inc
China Registration ClassN/A
Develop Information
Active CompaniesParadigm Therapeutics IncUniversitas Padjadjaran
Inactive CompaniesNational Cancer InstituteCha UniversityAmicus Therapeutics Inc +[5]
Active Indications
Inactive Indications +[5]